David Linetsky - Mar 18, 2025 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role
SVP, Life Sciences
Signature
/s/ Alexis Lyons by Power of Attorney for David Linetsky
Stock symbol
PHR
Transactions as of
Mar 18, 2025
Transactions value $
-$3,505
Form type
4
Date filed
3/20/2025, 05:01 PM
Previous filing
Feb 18, 2025
Next filing
Apr 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Sale -$1.05K -39 -0.44% $26.95 8.81K Mar 18, 2025 By Spouse F1, F2
transaction PHR Common Stock Sale -$2.26K -81 -0.92% $27.85 8.73K Mar 19, 2025 By Spouse F1, F3
transaction PHR Common Stock Sale -$198 -7 -0.08% $28.31 8.72K Mar 19, 2025 By Spouse F1, F4
holding PHR Common Stock 218K Mar 18, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.51 to $27.215 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.21 to $28.205 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.21 to $28.465 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.